Seguir
Federico Augustovski
Federico Augustovski
Director, Institute for Clinical Effectiveness and Health Policy - Professor, University of Buenos Aires School of Public Health - Principal researcher, CONICET
Dirección de correo verificada de iecs.org.ar - Página principal
Título
Citado por
Citado por
Año
Consolidated health economic evaluation reporting standards (CHEERS) statement
D Husereau, M Drummond, S Petrou, C Carswell, D Moher, D Greenberg, ...
Bmj 346, 2013
30812013
Consolidated health economic evaluation reporting standards (CHEERS)—explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good …
D Husereau, M Drummond, S Petrou, C Carswell, D Moher, D Greenberg, ...
Value in health 16 (2), 231-250, 2013
20212013
Budget impact analysis—principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force
SD Sullivan, JA Mauskopf, F Augustovski, JJ Caro, KM Lee, M Minchin, ...
Value in health 17 (1), 5-14, 2014
10352014
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
D Husereau, M Drummond, F Augustovski, E de Bekker-Grob, AH Briggs, ...
MDM Policy & Practice 7 (1), 23814683211061097, 2022
8282022
Cost-effectiveness analysis alongside clinical trials II—an ISPOR Good Research Practices Task Force report
SD Ramsey, RJ Willke, H Glick, SD Reed, F Augustovski, B Jonsson, ...
Value in health 18 (2), 161-172, 2015
7162015
Consolidated health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II good practices task force
D Husereau, M Drummond, F Augustovski, E de Bekker-Grob, AH Briggs, ...
Value in health 25 (1), 10-31, 2022
3162022
Declaración CONSORT 2010: actualización de la lista de comprobación para informar ensayos clínicos aleatorizados de grupos paralelos
A Cobos-Carbo, F Augustovski
Medicina clínica 137 (5), 213-215, 2011
2712011
Effect of a community health worker–led multicomponent intervention on blood pressure control in low-income patients in Argentina: a randomized clinical trial
J He, V Irazola, KT Mills, R Poggio, A Beratarrechea, J Dolan, CS Chen, ...
Jama 318 (11), 1016-1025, 2017
2012017
Argentine valuation of the EQ-5D health states
FA Augustovski, VE Irazola, AP Velazquez, L Gibbons, BM Craig
Value in health 12 (4), 587-596, 2009
1572009
ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force. Consolidated health economic evaluation reporting standards (CHEERS …
D Husereau, M Drummond, S Petrou, C Carswell, D Moher, D Greenberg, ...
Value Health 16 (2), 231-250, 2013
1432013
Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden …
A Rubinstein, L Colantonio, A Bardach, J Caporale, SG Martí, ...
BMC public health 10, 1-15, 2010
1262010
An EQ-5D-5L value set based on Uruguayan population preferences
F Augustovski, L Rey-Ares, V Irazola, OU Garay, O Gianneo, G Fernández, ...
Quality of Life Research 25, 323-333, 2016
1222016
Identifying the need for good practices in health technology assessment: summary of the ISPOR HTA council working group report on good practices in HTA
FB Kristensen, D Husereau, M Huić, M Drummond, ML Berger, K Bond, ...
Value in health 22 (1), 13-20, 2019
1112019
CHEERS 2022 ISPOR Good Research Practices Task Force. Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for …
D Husereau, M Drummond, F Augustovski, E de Bekker-Grob, AH Briggs, ...
Value Health 25 (1), 3-9, 2022
1042022
Estimación de la carga de las enfermedades cardiovasculares atribuible a factores de riesgo modificables en Argentina
A Rubinstein, L Colantonio, A Bardach, J Caporale, S García Martí, ...
Revista Panamericana de Salud Pública 27, 237-245, 2010
962010
Patient preferences for biologic agents in rheumatoid arthritis: a discrete-choice experiment
F Augustovski, A Beratarrechea, V Irazola, F Rubinstein, P Tesolin, ...
Value in health 16 (2), 385-393, 2013
942013
Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, Argentina
A Rubinstein, S García Martí, A Souto, D Ferrante, F Augustovski
Cost Effectiveness and Resource Allocation 7, 1-10, 2009
852009
The Argentine–Spanish SF-36 Health Survey was successfully validated for local outcome research
FA Augustovski, G Lewin, E García-Elorrio, A Rubinstein
Journal of clinical epidemiology 61 (12), 1279-1284. e6, 2008
812008
Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries
L Colantonio, JA Gomez, N Demarteau, B Standaert, A Pichon-Riviere, ...
Vaccine 27 (40), 5519-5529, 2009
792009
Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study
F Rubinstein, P Micone, A Bonotti, V Wainer, A Schwarcz, F Augustovski, ...
Bmj 346, 2013
762013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20